NCT07547917
Measurement of High Blood Pressure Using Boppli
Enrolling by Invitation
NAAges 0–9InterventionalDiagnosticIndiana UniversityInvestigator-initiated
~30 participants
Updated 2026-06-11 on ClinicalTrials.gov
What's tested:Boppli
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility and agreement of Boppli to cuff based measurements
Measured over 72 hours
Conditions
Where it's being run
1 sites across 1 statesIndiana1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Admitted to the neonatal intensive care unit (NICU)
Age 0 to 9 months at time of enrollment
Weight less than 5 kg
At risk for elevated blood pressure or with clinical concern for hypertension, -including but not limited to:
History of acute kidney injury or kidney disease
History of extracorporeal membrane oxygenation (ECMO)
Parent or legal guardian able to provide informed consent
Exclusion
Currently receiving extracorporeal membrane oxygenation (ECMO)
Currently receiving any form of extracorporeal dialysis (e.g., continuous renal -replacement therapy)
Presence of a ventricular assist device
Congenital anomalies or clinical conditions that prevent placement of the Boppli™ device
For Part 2 only: infants not expected to survive hospitalization
What this trial measures
- Feasibility and agreement of Boppli to cuff based measurements72 hours
Feasibility will be assessed by the proportion of successful blood pressure measurements obtained using the Boppli™ device during the monitoring period and user-reported ease of use. Agreement will be assessed by comparing measurements obtained from the Boppli™ device to those obtained from standard cuff-based measurements using paired measurements.